Latest Breaking News On - Natalie carfora - Page 1 : comparemela.com

Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studies

Studies demonstrate real-world clinical utility of EsoGuard testing to detect esophageal precancer NEW YORK, Dec. 12, 2023 /PRNewswire/  Lucid Diagnostics Inc. a commercial-stage, cancer.

Lucid Diagnostics Strengthens and Expands Market Access and Direct Contracting Efforts

Industry veterans join executive team as VP, Market Access and VP, Employer Markets Shaun M. O Neil promoted to Lucid s President and COO NEW YORK, Nov. 16, 2023 /PRNewswire/  Lucid Diagnostics.

Lucid Diagnostics Inc (LUCD) Strengthens and Expands Market Access and Direct Contracting Efforts

Lucid Diagnostics Releases Positive Data Demonstrating Clinical Utility of EsoGuard® Esophageal Precancer Detection in Fire Fighters

Study documents 100 percent concordance between EsoGuard® test results and subsequent medical decision-making Timely results support recently proposed federal legislation which seeks to fund.

Lucid Diagnostics (LUCD) Releases Positive Data Demonstrating Clinical Utility of EsoGuard Esophageal Precancer Detection